表紙:補助人工心臓の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)
市場調査レポート
商品コード
1029059

補助人工心臓の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)

Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 148 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
補助人工心臓の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)
出版日: 2021年09月16日
発行: IMARC Services Private Limited
ページ情報: 英文 148 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の補助人工心臓の市場規模は、2015年から2020年にかけて力強い成長見せており、2021年から2026年の間には約10%のCAGRで成長すると予測されています。高血圧症、心室中隔欠損症、心不全、脳卒中などの心血管疾患の増加は、同市場の成長を促進する重要な要因の一つです。さらに、心臓提供者数が限られていることが、世界における補助人工心臓の需要を高めています。

この問題を解決するために、医療関係者は、新しい心臓が移植されるまでの間、血液を送り続けるための補助人工心臓の利用に注目しています。これにより、病院内の死亡率、入院期間、病院の総費用を削減することができます。さらに、業界の大手メーカーは、感染症のリスクが高く、血栓形成や血液外傷などの合併症に対処するために、感染制御技術を備えた小型機器などの技術的進歩を取り入れています。

当レポートは、世界の補助人工心臓市場について調査しており、市場実績、COVID-19による影響、製品・フロータイプ・製品タイプ・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の補助人工心臓市場

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 製品別の市場セグメンテーション

  • 左心室補助装置(LVAD)
  • 右心室補助装置(RVAD)
  • 両心室補助装置(BiVAD)
  • その他

第7章 フロータイプ別の市場セグメンテーション

  • 拍動流
  • 非拍動流または連続流

第8章 製品タイプ別の市場セグメンテーション

  • 埋込み型補助人工心臓
  • 非埋込み型補助人工心臓

第9章 用途別の市場セグメンテーション

  • 心臓移植までの橋渡し(BTT)療法
  • 長期在宅治療
  • 心機能回復までの橋渡しおよび移植適応判定までの橋渡し

第10章 エンドユーザー別市場セグメンテーション

  • 外来手術センター
  • 病院
  • その他

第11章 地域別の市場セグメンテーション

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 国別の市場セグメンテーション

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格指標

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Abiomed Inc.
    • Berlin Heart GmbH(Syscore GmbH)
    • Bivacor Inc.
    • Calon Cardio
    • Cardiacassist Inc.(LivaNova PLC)
    • CHF Solutions Inc.
    • Jarvik Heart Inc.
    • MAQUET GmbH(Getinge)
    • Medtronic Inc.
    • Syncardia Systems LLC(Versa Capital Management LLC)
    • TandemLife(LivaNova Plc)
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
  • Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2020
  • Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2020
  • Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2020
  • Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2020
  • Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2020
  • Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
  • Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
  • Figure 88: Global: Ventricular Assist Device Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million US$), 2021-2026
  • Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
  • Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million US$), 2021-2026
  • Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 8: Global: Ventricular Assist Device Market Structure
  • Table 9: Global: Ventricular Assist Device Market: Key Players
目次
Product Code: SR1020F09_Report

The global ventricular assist device market exhibited strong growth during 2015-2020. A ventricular assist device (VAD), also known as a mechanical circulatory support device, is a mechanical pump that transports blood from the lower chambers of the heart to the rest of the body. It generally comprises three components, which include tubes, an electronic controller and a power source. The tubes carry blood into the pump and transfer it into blood vessels, while the power source is connected to a control unit for monitoring the functions of the VAD. The device is implanted in patients as a short-term treatment for supporting heart functions after surgery or while they are waiting for a heart transplant. It finds application in the bridge-to-transplant (BTT), bridge-to-recovery (BTR), bridge-to-candidacy (BTC) and destination therapies.

The increasing cases of cardiovascular diseases, such as hypertension, ventricular septal defect, heart failure and stroke, represents one of the significant factors propelling the global VAD market growth. Moreover, the limited number of heart donors is escalating the demand for VADs across the globe. In order to overcome this shortage, healthcare providers are focusing on the utilization of VADs to keep the blood pumping until a new heart is implanted. This helps in reducing the in?hospital mortality rate, length of stay and overall hospital costs. Furthermore, the leading manufacturers in the industry are incorporating technological advancements, such as miniature devices with infection control technology, to address complications, such as the high risk of infection, thrombus formation and blood trauma. Apart from this, several clinical trials are being undertaken to improve the survival rate by enhancing the durability, functionality and efficiency of the devices. Looking forward, IMARC Group expects the global ventricular assist device market to grow at a CAGR of around 10% during 2021-2026.

Breakup by Product:

  • Left Ventricular Assist Device (LVAD)
  • Right Ventricular Assist Device (RVAD)
  • Biventricular Assist Device (BiVAD)
  • Others

Breakup by Flow Type:

  • Pulsatile Flow
  • Non-Pulsatile or Continuous Flow

Breakup by Product Type:

  • Implantable Ventricular Assist Devices
  • Non-implantable Ventricular Assist Devices

Breakup by Application:

  • Bridge-to-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge to Recovery and Bridge to Candidacy

Breakup by End-User:

  • Ambulatory Surgery Centers
  • Hospital
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH (Syscore GmbH), Bivacor Inc., Calon Cardio, Cardiacassist Inc. (LivaNova PLC), CHF Solutions Inc., Jarvik Heart Inc., MAQUET GmbH (Getinge), Medtronic Inc., Syncardia Systems LLC (Versa Capital Management LLC), TandemLife (LivaNova PLC), Terumo Corporation, etc.

Key Questions Answered in This Report:

  • How has the global ventricular assist device market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global ventricular assist device market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the flow type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global ventricular assist device market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ventricular Assist Device Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Left Ventricular Assist Device (LVAD)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Right Ventricular Assist Device (RVAD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biventricular Assist Device (BiVAD)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Flow Type

  • 7.1 Pulsatile Flow
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Pulsatile or Continuous Flow
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product Type

  • 8.1 Implantable Ventricular Assist Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-implantable Ventricular Assist Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Bridge-to-Transplant (BTT) Therapy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Destination Therapy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Bridge to Recovery and Bridge to Candidacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Ambulatory Surgery Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Abiomed Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Berlin Heart GmbH (Syscore GmbH)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Bivacor Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Calon Cardio
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Cardiacassist Inc. (LivaNova PLC)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 CHF Solutions Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Jarvik Heart Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 MAQUET GmbH (Getinge)
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Medtronic Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 SWOT Analysis
    • 16.3.12 TandemLife (LivaNova Plc)
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 Terumo Corporation
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis